The president & CEO of Ocular Therapeutix (NSDQ:OCUL), Amarpreet Sawhney, is slated to step down from the company that he helped start in 2006.
He will serve as the board’s executive chairman for 1 year, unless he decides to leave earlier. The company wrote in a regulatory filing that “his service will be automatically renewed for an additional 1-year term upon each successive anniversary of the transition date.”
Antony Mattessich was named president & CEO in place of Sawhney, effective Sept. 18. He joins the company from Mundipharma International, where he worked as managing director since May of 2011.
Get the full story at our sister site, Drug Delivery Business News.
The post Ocular Therapeutix founder & CEO Sawhney to step down | Personnel Moves – April 13, 2017 appeared first on MassDevice.
from MassDevice http://ift.tt/2tWMS21
Cap comentari:
Publica un comentari a l'entrada